UiPath Stock Steadies As AI Orchestration Story Gains Momentum

UiPath Inc. stocks have been trading up by 5.78 percent on strong optimism around its expanding AI automation platform.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading PATH

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Q2 FY27 revenue came in around $410M, up 13% year over year, with ARR at $1.94B and gross margins above 80%, all ahead of UiPath management’s own guidance.
Full-year FY27 revenue guidance ticked up to $1.789B–$1.794B, with ARR targeted at $2.065B–$2.07B, reinforcing a mid-teens growth and profitability narrative.
Near-term Q3 guidance of $440M–$445M in revenue and ARR of $1.992B–$1.997B tracks closely with Street expectations, pointing to steady, not explosive, momentum.
Citi launched coverage of UiPath (PATH) with a Buy rating and $23 target, while RBC, BMO, and Barclays all lifted price targets after the beat-and-raise quarter.
Leadership changes, including Hitesh Ramani becoming CFO and a new board member focused on transformation, aim to support UiPath’s push into AI business orchestration.

Live Update At 15:04:26 EDT: On Monday, September 14, 2026 UiPath Inc. stock [NYSE: PATH] is trending up by 5.78%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

PATH has been on a wild ride lately, and the chart shows it. At the end of August, UiPath traded near $18–$19. After earnings and guidance, PATH slid sharply, with the close on 2026/09/04 at $15.19 and more pressure into 2026/09/09, where it finished at $13.57. That’s a fast reset in sentiment despite solid fundamentals.

Over the last few days, PATH has been trying to base. The stock closed at $13.87 on 2026/09/10 and then bounced to $13.75 and $14.545 on 2026/09/11 and 2026/09/14. Intraday action on the latest session shows a slow grind higher from the low $14s to the mid-$14s, with tight five‑minute candles and low volatility in the afternoon. That tells traders sellers are getting exhausted, at least short term.

More Breaking News

Fundamentally, UiPath is now posting roughly $410M in quarterly revenue with about 83% gross margins and positive operating income. PATH carries very little debt, a strong current ratio above 2, and free cash flow around $29M for the latest quarter. For active traders, that combo of high-margin growth, improving profitability, and a sharp pullback on the chart sets up a classic “strong company, weak stock” scenario to study.

Why Traders Are Watching PATH After The Beat-And-Raise

UiPath gave traders a clean fundamental story in Q2 FY27. Revenue grew 13% year over year to roughly $410M, beating expectations. Annualized recurring revenue reached about $1.94B, up 12%. Gross margins topped 80%, and both GAAP and non‑GAAP operating income were positive. For an AI and automation name, that’s not just growth; it’s growth with real operating leverage.

Management didn’t stop there. UiPath raised FY27 revenue guidance to $1.789B–$1.794B and pushed ARR guidance to $2.065B–$2.07B. Those are modest bumps, but the message is clear: demand is holding, and PATH expects mid‑teens growth with expanding profitability. Q3 revenue and ARR guidance are basically in line with Street numbers, which signals steady pipelines rather than a blowout acceleration.

On the Street side, Citi initiated coverage of PATH with a Buy rating and a $23 price target, calling UiPath a potential “control plane” for enterprise AI. That’s a powerful framing for traders tracking long‑term AI infrastructure plays. At the same time, RBC, BMO, and Barclays all raised their price targets into the mid‑teens to high‑teens range while keeping more neutral ratings. The takeaway: fundamentals are improving, but many analysts still want more proof of sustained growth before getting aggressive.

Strategically, UiPath is rolling out Maestro Case and Maestro Flow to move beyond basic RPA into full business orchestration. A global survey the company released says most enterprises are stuck running agentic AI in limited pilots thanks to data and governance headaches. UiPath is pitching PATH’s platform as the orchestration layer that turns those pilots into large‑scale deployments. Deals like PLDT in telecom, where automation drove measurable productivity gains, give traders a real‑world proof point that the platform can scale in demanding industries.

Conclusion

For traders, PATH now sits at an interesting crossroads. On one hand, UiPath just delivered a beat‑and‑raise quarter, boosted full‑year guidance, and showed it can grow in the low‑teens while staying profitable on both GAAP and non‑GAAP bases. The balance sheet is clean, gross margins are elite, and free cash flow is positive. On the other hand, the stock sold off hard post‑earnings and is only starting to stabilize in the mid‑$14s after trading near $18–$19 just weeks ago.

That disconnect is exactly what active traders love to study. Leadership changes — Hitesh Ramani stepping in as CFO, Ashim Gupta focusing on the COO role, and a transformation veteran joining the board — are designed to align UiPath for its next phase in AI business orchestration. If the Maestro product line and the “control plane for AI” story catch on, PATH could see sentiment reset, especially with multiple price target hikes already on the tape and Citi’s $23 target framing upside potential.

Still, nothing is guaranteed. Subscription growth has lagged services and licenses at times, and guidance suggests steady rather than explosive near‑term momentum. This is where process matters. As Tim Sykes often says, “Trade like a sniper, not a machine gun — wait for the best setups and cut losses quickly.” As Tim Bohen, lead trainer with StocksToTrade says, “There’s a pattern in everything; you just have to stick around long enough to see it.”, and that mindset can help traders focus on waiting for clean, high‑probability chart patterns instead of forcing trades. For PATH, that means watching how the stock behaves around key support and prior resistance, tracking volume on any breakout, and treating every trade as a planned, risk‑managed bet — not a prediction. This article is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!